Hein is a healthcare actuary from Cape Town, South Africa. He studied Actuarial Science at the University of Stellenbosch, South Africa, and is a Fellow of the Institute and Faculty of Actuaries in the United Kingdom.
He commenced his career in 1995 as an actuarial consultant with Sanlam, a large South African insurer, in the field of employee benefits. Between 2000 and 2005 he was the lead actuarial advisor to four medical insurance clients for Medscheme, at the time the largest third party administrator in South Africa.
In 2005 he joined Mediclinic Southern Africa as Business Development Manager and in 2009 was tasked with creating a Health Policy Unit to focus on healthcare reform including National Health Insurance, pricing reform and quality regulations. He was a member of the Hospital Association of South Africa’s Reference Price List and NHI sub-committees.
In March 2014 he moved to Dubai and joined Mediclinic Middle East to head up the Funder Relations function, which is responsible for tariff negotiations with health insurance companies, revenue cycle management and health policy.
Following the merger of Mediclinic Middle East and Al Noor Hospitals Group in February 2016, Hein was appointed as Chief Strategy Officer for the combined group. This position still entails oversight of Funder Relations, Revenue Cycle Management and Health Policy, with the addition of Business Performance Improvement, which provides support in developing, driving and tracking strategic goals.
